Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers [Phase 1]

View source ↗

Summary

An early Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Fx-5A in healthy volunteers, sponsored by NHLBI, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Fx-5A (Fx-5A)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Disease | Phase 1 | Status: RECRUITING